Includes | COVID-19 disease (due to infection with SARS-CoV-2 virus, previously known as Novel Coronavirus or 2019-nCoV). | ||||||
| |||||||
| |||||||
| |||||||
See if Relevant | Coronavirus Vaccination | ||||||
Additional Information | Common coronaviruses cause colds and respiratory tract infections but are not considered a risk for tissue transplant recipients. Since 2002 there have been outbreaks in humans of new strains of coronavirus, associated with severe pulmonary infections and mortality rates of 10-35% e.g. SARS and MERS.
| ||||||
Post Donation Illness | Donors must be provided with information about contacting the tissue establishment if they develop any illness within 14 days after donation | ||||||
Reason for Change | Delete outdated information in the definition section, and ‘additional information’ section. |
This entry was last updated in
TDSG-CB Edition 203, Release 52